Journal article
General practitioner-delivered adherence counseling in asthma: Feasibility and usefulness of skills, training and support tools
JM Foster, L Smith, T Usherwood, SM Sawyer, HK Reddel
Journal of Asthma | Published : 2016
Abstract
Objective: Poor medication adherence contributes to uncontrolled asthma in primary care. Good doctor-patient communication around adherence increases patients medication taking but general practitioners (GPs) often feel poorly equipped to provide effective adherence counseling. This study aimed to assess the feasibility and usefulness of adherence counseling training, skills and support tools for GPs. Methods: Twenty-five GPs enrolled in a 6-month cluster randomized-controlled trial of adherence interventions for asthma were randomized to an intervention delivering personalized adherence discussions. They received 2 hours training in delivering brief, motivational-interviewing-based adherenc..
View full abstractGrants
Funding Acknowledgements
[ "Dr Foster has provided independent continuing medical education for GlaxoSmithKline, Pharmaceutical Society of Australia and AstraZeneca and has participated in an advisory board for Vertex Pharmaceuticals. Dr Smith has provided independent continuing medical education for Pharmaceutical Society of Australia. A/Prof. Reddel has participated in advisory boards and/or data monitoring and safety boards for AstraZeneca, GlaxoSmithKline, Merck and Novartis, has received consultancy fees and/or provided independent continuing medical education for Mundipharma, GlaxoSmithKline, AstraZeneca and Novartis, and has received unrestricted research grants from AstraZeneca and GlaxoSmithKline. Prof. Usherwood and Prof. Sawyer have no potential conflicts of interest to report with respect to this article. The authors alone are responsible for the content and writing of the paper.", "Funding for this study was provided by NHMRC Australia. The Asthma Control Test was used with permission of GlaxoSmithKline and in accordance with conditions specified by GlaxoSmithKline under the terms of its license with the copyright holder, QualityMetric Incorporated. None of the above bodies had any role in the design, conduct, analysis or interpretation of the study, nor did they see the manuscript prior to submission." ]